Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Conditions

Hepatic Veno-Occlusive Disease

What is the purpose of this trial?

Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism (also known as compassionate use, or single patient named use). This protocol is the only mechanism by which Defibrotide can be made available to patients in the U.S.



Participation Guidelines

Age:
N/A - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Gentium SpA
Dates:
December 2007
Last Updated:
January 13, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00628498